New Flowserve digital positioner features predictive diagnostics
Flowserve Corporation, a leading provider of flow control products and services for the global infrastructure markets, has announced the release of the Flowserve Logix 3400MD, the newest member of the Logix series digital positioner family
'Next-generation facilities use Foundation Fieldbus technology because it allows easy integration of field instruments into a central control system,' said Ken Beatty, Director of Advanced Product Development, Flowserve Flow Control Division. 'The Logix 3400MD helps plant operators run their control processes more efficiently by identifying issues before they become costly failures.'
The Logix 3400MD uses Flowserve ValveSight technology to monitor the status of the valve, actuator and positioner, and the health of the entire control loop. Proprietary models provide predictive diagnostics, which give advanced warning of future equipment or process problems.
The Flowserve Logix 3400MD features the same proven, state-of-the-art technology as the Logix 3200MD to provide superior performance and reliability. It is certified by all major digital control system suppliers, the FDT Group and the Fieldbus Foundation.
For more information about the Logix 3400MD digital positioner, please call a Flowserve sales representative at +1 800 225-6989.
You may also like
Trending Articles
You may also like
Manufacturing
Virica Biotech and FUJIFILM Biosciences collaborate to boost AAV vector yields in HEK293 manufacturing system
Virica Biotech has announced a collaboration with FUJIFILM Biosciences to co-develop an off-the-shelf enhancer-media solution combining Virica's VSE technology with FUJIFILM's BalanCD HEK293 system, targeting improved AAV productivity and process robustness for gene therapy manufacturers
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Accelerating the development of bispecific antibodies
Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains how the use of comprehensive tailored approaches can enhance bispecific antibody productivity, stability and quality while accelerating their delivery to market
Manufacturing
Nemera partners with Therakind to expand nasal drug delivery portfolio with DriDose dry powder platform
The manufacturer has announced a strategic partnership with UK pharmaceutical company Therakind to advance the DriDose intranasal dry powder platform, adding dry powder delivery capabilities to complement Nemera's existing liquid nasal formulation offering